Latest News and Press Releases
Want to stay updated on the latest news?
-
Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 U.S. NDA submission on track for summer 2026Nicox to receive milestone payment from Kowa upon submission...
-
PRINCETON, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its fourth quarter and full year 2025...
-
Modern Vision Centers Publishes New Resource on Choosing a Cataract Surgeon in West Des Moines, Iowa
West Des Moines, Iowa, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Modern Vision Centers has published a new educational article titled How to Choose a Cataract Surgeon in West Des Moines, Iowa, designed to...
-
Austin, TX, USA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Large And Small Scale Bioprocessing Market Size, Trends and Insights By Scale...
-
MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January...
-
MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January...
-
Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli...
-
Hyderabad, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the dental lasers market size is valued at approximately USD 401.30 million in 2026 and is projected to grow to USD...
-
Press Release Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026February 10, 2026 – release at 7:30 am Sophia Antipolis, FranceNicox SA (Euronext...
-
Enrollment for 4FRONT-1, the first registrational trial for 4D-150 in wet AMD, was completed within an approximately 11-month period, ahead of initial projections 4FRONT-1 overenrolled and expected to...